More about

Hereditary Angioedema

News
April 21, 2023
3 min read
Save

Providers urged to do more to help patients access care for hereditary angioedema

It was with pleasure that we had the opportunity to review a manuscript written by our colleagues titled “Challenges in the management of hereditary angioedema in urban and rural settings: Results of a United States survey.”

News
April 06, 2023
6 min read
Save

Multiple obstacles make hereditary angioedema diagnosis, treatment difficult

Clinical and economic factors make hereditary angioedema difficult to diagnose and treat, particularly among patients who live in rural areas, according to a study published in Annals of Allergy, Asthma & Immunology.

News
March 16, 2023
3 min read
Save

Insurance delays, denials negatively impact patients with hereditary angioedema

SAN ANTONIO — Insurance delays and denials for hereditary angioedema medication have a negative impact on physical and mental health, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

News
March 16, 2023
3 min read
Save

On-demand sebetralstat treatment reduces hereditary angioedema attack symptoms, severity

SAN ANTONIO — Sebetralstat significantly reduced cumulative hereditary angioedema attack and symptom severity compared with placebo, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

News
March 03, 2023
2 min read
Save

Top news of February: COVID-19 vaccines, ocular surface disease, FDA approvals, more

Healio compiled the most-read news in allergy, asthma and immunology posted in February.

News
February 26, 2023
3 min read
Save

Garadacimab significantly reduces hereditary angioedema attack rates

SAN ANTONIO — Garadacimab significantly reduced attack rates among patients with hereditary angioedema and was well tolerated, according to an abstract presented at the American Academy of Allergy, Asthma & Immunology Annual meeting.

News
February 07, 2023
1 min read
Save

FDA approves expanded use of Takhzyro for children with hereditary angioedema

The FDA has approved a supplemental biologics license application to expand the use of lanadelumab-flyo for prophylaxis of hereditary angioedema attacks in children aged 2 to younger than 12 years, according to a press release.

News
December 12, 2022
3 min read
Save

C1 inhibitor deficiency linked to greater activation of coagulation, enhanced VTE

Endogenous C1 esterase inhibitor is an important negative regulator of coagulation, according to study results presented at ASH Annual Meeting and Exposition.

News
November 21, 2022
3 min read
Save

Hereditary angioedema impacts quality of life, mental health

LOUISVILLE, Ky. — Hereditary angioedema has a significant effect on mental health, daily activities and quality of life, according to a study presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

News
November 15, 2022
3 min read
Save

CRISPR-based therapy shows promise for reducing hereditary angioedema attacks

LOUISVILLE, Ky. — All patients treated with one infusion of NTLA-2002 gene therapy have remained hereditary angioedema attack-free, according to data presented at American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

View more